Frances Alice Shepherd

Last updated

Frances Alice Shepherd, OC OOnt is a Canadian oncologist recognized for her research on lung cancer and her contributions to the design, development, and conduct of clinical trials. She is currently a senior staff physician at Princess Margaret Cancer Centre, where she has held the Scott Taylor Chair in Lung Cancer Research since 2001, and she is a full professor in the Department of Medicine at the University of Toronto.

Contents

Contributions

Shepherd has been a co-investigator or principal investigator in over 100 clinical trials and authored more than 450 peer-reviewed publications and 35 book chapters. [1] She is on the editorial board of several journals, including the Journal of Clinical Oncology, as well as on numerous lung cancer advisory boards and data and safety monitoring boards for international lung cancer trials. [2] She has mentored more than 30 post-doctoral research fellows. [1]

Her past work includes serving as President of the International Association for the Study of Lung Cancer, a member of the United States National Institutes of Health Concept Evaluation Panel, Chair of the Lung Cancer Committees of the National Cancer Institute of Canada Clinical Trials Group, Chair of the American Society of Clinical Oncology Membership and Publications Committees, and the Princess Margaret Cancer Centre's Lung Cancer Site Group Leader. [2]

Awards

Shepherd has been the recipient of numerous awards.

Related Research Articles

M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri, in 2001 for his contributions in the cancer care field.

<span class="mw-page-title-main">European Organisation for Research and Treatment of Cancer</span> International nonprofit organization

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.

<span class="mw-page-title-main">Cediranib</span> Chemical compound

Cediranib is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.

Gregory Bruce Mann is a surgical oncologist and Director of Breast Cancer Services at the Royal Women's Hospital in Melbourne, Australia, the largest specialist women's care hospital in Australia. A former president of COSA, Dr. Mann served previously as Director of Cancer Services and Infectious Medicine for the Melbourne Health Cancer Service, as Director of the award-winning Melbourne Health Combined Breast Service and is Director of Advanced Surgical Training at the Royal Melbourne Hospital. The Combined Breast Service won the prestigious Premier's Award for "Excellence for improving cancer care in Victoria" under Mann's direction in 2008.

<span class="mw-page-title-main">Edinburgh Cancer Research Centre</span> Medical facility in City of Edinburgh, Scotland, UK

The Edinburgh Cancer Research Centre (ECRC), also known as the Cancer Research UK Edinburgh Centre and the University of Edinburgh Cancer Research Centre, is a center for basic, translational and clinical cancer research located in Edinburgh, Scotland. ECRC constitutes a part of the Institute of Genetics & Molecular Medicine (IGMM) and is positioned in direct proximity of the Western General Hospital, where most of its clinical activities take place.

Kathleen I. Pritchard, is the head of oncology at Sunnybrook Health Sciences Centre in Toronto, Canada, specializing in breast cancer therapies, and leading the clinical trials division of the centre. She has authored numerous studies on women's health, breast cancer, hormone replacement therapy, public health, and research methodology. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.

<span class="mw-page-title-main">Julie Ann Sosa</span> American actress

Julie Ann Sosa, MD, MA, FACS, is professor and chair of the Department of Surgery at the University of California, San Francisco (UCSF) and holds the Leon Goldman, MD, Distinguished Professorship in Surgery. She currently serves as the Treasurer of the American Thyroid Association and Editor-in-Chief of the World Journal of Surgery.

Margaret Ruth McCorkle FAAN, FAPOS was an international leader and award-winning pioneer in oncology nursing. She was the Florence Schorske Wald Professor of Nursing at the Yale School of Nursing.

Barbara Anne Croy is a Canadian reproductive immunologist and professor emerita in Biomedical and Molecular Sciences at Queen's University. From 2004 until 2016, Croy was a Canada Research Chair in Reproduction, Development and Sexual Function. In 2017, she was elected a Fellow of the Royal Society of Canada. Her research focus is on mice pregnancy and natural killer cells.

Elizabeth Eisenhauer is a Canadian oncologist who has spent a large portion of her career undertaking phase I and II trials of novel cancer therapies through her role as Director of the Investigational New Drug Program in the Canadian Cancer Trials Group. She received her Doctor of Medicine degree from Queen's University and was trained in internal medicine and hematology, obtaining fellowships from the Royal College of Physicians and Surgeons of Canada.

<span class="mw-page-title-main">Terri S. Armstrong</span> American scientist

Terri S. Armstrong is an American scientist and nurse practitioner. She is a senior investigator in the Center for Cancer Research Neuro-Oncology Branch of the National Cancer Institute. Armstrong held the Dunn Distinguished Professorship in Oncology Nursing at UTHealth Jane and Robert Cizik School of Nursing.

Deborah Watkins Bruner is an American researcher, clinical trialist, and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes, symptom management across cancer sites, sexuality after cancer treatment, and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998, with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012, according to the Blue Ridge Institute for Medical Research.

Pamela Sumiko Ohashi, PhD, FRSC is a Canadian medical researcher. She is co-director of the Campbell Family Institute for Breast Cancer Research, director of the Cancer Immune Therapy Program at the Princess Margaret Cancer Centre and a professor at the University of Toronto.

Folakemi Titilayo Odedina is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC), a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team.

Janet Dancey is a Canadian oncologist. In 2014, she was appointed director of the NCIC Clinical Trials Group and received a second term in 2020. In the same year, Dancey was also elected a Fellow of the Canadian Academy of Health Sciences.

Mary K. Gospodarowicz Evans is a Canadian oncologist. She is a University Professor at the University of Toronto and Medical Director at the Princess Margaret Cancer Centre.

Kerry Stephen Courneya is a Canadian kinesiologist. As a Full Professor and Canada Research Chair in Physical Activity and Cancer at the University of Alberta, his research focuses on physical activity after a cancer diagnosis.

Sophie Postel-Vinay is a French physician and scientist at the Institut Gustave Roussy where she has led an ATIP-Avenir team since 2018. She works on oncology and the development of new drugs and is an expert in early clinical trials. She was the 2019 winner of the Irène Joliot-Curie Prize in the “young woman scientist” category.

Valerie W Rusch, MD, FACS, is an American thoracic surgeon who is currently the Miner Family Chair for Intrathoracic Cancers and Vice Chair for Clinical Research, Department of Surgery, at Memorial Sloan Kettering Cancer Center.

Julie Renee Brahmer is an American thoracic oncologist. She is the Co-Director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University and the Marilyn Meyerhoff Professor in Thoracic Oncology.

References

  1. 1 2 3 "Recognition Awards | Canadian Cancer Trials Group". www.ctg.queensu.ca. Retrieved 2016-09-21.
  2. 1 2 "Dr. Frances A. Shepherd". www.ctg.queensu.ca. Retrieved 2016-09-21.
  3. 1 2 3 "Dr. Frances Shepherd recognized for her contributions to lung cancer treatment". The Princess Margaret Cancer Foundation. Retrieved 2016-09-21.
  4. "Premier's Summit Award in Medical Research" . Retrieved 2016-09-21.
  5. "Frances A Shepherd | UHN Research". www.uhnresearch.ca. Retrieved 2016-09-21.
  6. "Order of Canada Appointments". The Office of the Governor General of Canada. December 30, 2015. Retrieved 2016-09-21.